These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 6603264)
1. Effect of 2'-deoxycoformycin infusion on S-adenosylhomocysteine hydrolase and the amount of S-adenosylhomocysteine and related compounds in tissues of mice. Helland S; Ueland PM Cancer Res; 1983 Sep; 43(9):4142-7. PubMed ID: 6603264 [TBL] [Abstract][Full Text] [Related]
2. S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in various tissues of mice given injections of 9-beta-D-arabinofuranosyladenine. Helland S; Ueland PM Cancer Res; 1983 Apr; 43(4):1847-50. PubMed ID: 6831422 [TBL] [Abstract][Full Text] [Related]
3. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine. Hershfield MS; Kredich NM; Koller CA; Mitchell BS; Kurtzberg J; Kinney TR; Falletta JM Cancer Res; 1983 Jul; 43(7):3451-8. PubMed ID: 6601986 [TBL] [Abstract][Full Text] [Related]
4. Effect of 9-beta-D-arabinofuranosyladenine and erythro-9-(2-hydroxy-3-nonyl) adenine on the metabolism of S-adenosylhomocysteine, S-adenosylmethionine, and adenosine in rat liver. Eloranta TO; Kajander EO; Raina AM Med Biol; 1982 Oct; 60(5):272-7. PubMed ID: 7154718 [TBL] [Abstract][Full Text] [Related]
5. Reactivation of S-adenosylhomocysteine hydrolase activity in cells exposed to 9-beta-D-arabinofuranosyladenine. Helland S; Ueland PM Cancer Res; 1982 Jul; 42(7):2861-6. PubMed ID: 6979384 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes. Bontemps F; Van den Berghe G Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493 [TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity of deoxycoformycin: effect of constant infusion on adenosine deaminase, adenosine, 2'-deoxyadenosine and monoamines in the mouse brain. Helland S; Broch OJ; Ueland PM Neuropharmacology; 1983 Jul; 22(7):915-7. PubMed ID: 6604884 [TBL] [Abstract][Full Text] [Related]
8. The effect of aliphatic adenine analogues on S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in intact rat hepatocytes. Schanche JS; Schanche T; Ueland PM; HolĂ˝ A; Votruba I Mol Pharmacol; 1984 Nov; 26(3):553-8. PubMed ID: 6493210 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of S-adenosylhomocysteine hydrolase by 9-beta-D-arabinofuranosyladenine in intact cells. Helland S; Ueland PM Cancer Res; 1982 Mar; 42(3):1130-6. PubMed ID: 7059972 [TBL] [Abstract][Full Text] [Related]
10. Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells. Hasobe M; Mckee JG; Borcherding DR; Keller BT; Borchardt RT Mol Pharmacol; 1988 Jun; 33(6):713-20. PubMed ID: 2454388 [TBL] [Abstract][Full Text] [Related]
11. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients. Hershfield MS; Kredich NM; Ownby DR; Ownby H; Buckley R J Clin Invest; 1979 Apr; 63(4):807-11. PubMed ID: 312296 [TBL] [Abstract][Full Text] [Related]
12. Disposition of homocysteine and S-3-deazaadenosylhomocysteine in cells exposed to 3-deazaadenosine. Svardal A; Djurhuus R; Ueland PM Mol Pharmacol; 1986 Aug; 30(2):154-8. PubMed ID: 3736540 [TBL] [Abstract][Full Text] [Related]
13. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor. Ratech H; Thorbecke GJ; Hirschhorn R Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339 [No Abstract] [Full Text] [Related]
14. Determination of S-adenosylhomocysteine in tissues following pharmacological inhibition of S-adenosylhomocysteine catabolism. Helland S; Ueland PM Adv Exp Med Biol; 1986; 195 Pt B():663-6. PubMed ID: 3490128 [No Abstract] [Full Text] [Related]
15. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine. Grever MR; Siaw MF; Coleman MS; Whisler RL; Balcerzak SP J Immunol; 1983 Jan; 130(1):365-9. PubMed ID: 6600187 [No Abstract] [Full Text] [Related]
16. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia. Yu AL; Bakay B; Kung FH; Nyhan WL Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800 [TBL] [Abstract][Full Text] [Related]
17. Recovery of 2'-deoxycoformycin-inhibited adenosine deaminase of mouse erythrocytes and leukemia L1210 in vivo. Agarwal RP Cancer Res; 1979 Apr; 39(4):1425-7. PubMed ID: 421226 [TBL] [Abstract][Full Text] [Related]
18. In vivo inhibition of mouse liver methyltransferase enzymes following treatment with 2'-deoxycoformycin and 2'-deoxyadenosine. Renshaw J; Harrap KR Adv Exp Med Biol; 1986; 195 Pt B():673-5. PubMed ID: 3490129 [No Abstract] [Full Text] [Related]
19. S-adenosylhomocysteine hydrolase activity, deoxyadenosine triphosphate accumulation, and competence of thymocyte and spleen leucocyte response to mitogens in coformycin-treated mice. Lukey T; Snyder FF Biochem Pharmacol; 1983 Apr; 32(8):1399-406. PubMed ID: 6860359 [TBL] [Abstract][Full Text] [Related]
20. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin. Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]